KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Accounts Payables (2020 - 2025)

Historic Accounts Payables for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to $10.7 million.

  • Ginkgo Bioworks Holdings' Accounts Payables fell 3182.17% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year decrease of 3182.17%. This contributed to the annual value of $14.2 million for FY2024, which is 5197.9% up from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' Accounts Payables stood at $10.7 million, which was down 3182.17% from $11.2 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' Accounts Payables' 5-year high stood at $35.3 million during Q1 2022, with a 5-year trough of $1.4 million in Q1 2021.
  • Its 5-year average for Accounts Payables is $14.0 million, with a median of $11.3 million in 2025.
  • In the last 5 years, Ginkgo Bioworks Holdings' Accounts Payables soared by 237971.43% in 2022 and then plummeted by 5826.26% in 2025.
  • Quarter analysis of 5 years shows Ginkgo Bioworks Holdings' Accounts Payables stood at $8.2 million in 2021, then increased by 27.62% to $10.5 million in 2022, then fell by 10.79% to $9.3 million in 2023, then soared by 51.98% to $14.2 million in 2024, then dropped by 24.45% to $10.7 million in 2025.
  • Its Accounts Payables was $10.7 million in Q3 2025, compared to $11.2 million in Q2 2025 and $11.3 million in Q1 2025.